Compare BioNTech SE - ADR (BNTX) vs Medtronic PLC (MDT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNTech SE - ADR vs Medtronic PLC — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while Medtronic PLC trades at $90.25 (market cap $116.07B). The key difference: Medtronic PLC is far larger — about 5× BioNTech SE - ADR's market cap, and Medtronic PLC pays a 3.18% dividend while BioNTech SE - ADR pays none. Which is the better fit depends on your goals.
| BNTX | MDT | |
|---|---|---|
Market Cap | $23.31B | $116.07B |
Sector | Health | Health |
52-Week High | $119.34 | $105.35 |
52-Week Low | $83.89 | $73.75 |
Enterprise Value | $6.60B | $134.82B |
Dividend Yield | — | 3.18% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BioNTech SE - ADR
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →About Medtronic PLC
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →
